Abivax
ABVX
40 hedge funds and large institutions have $313M invested in Abivax in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
55% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 11
5% more funds holding
Funds holding: 38 → 40 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.39% less ownership
Funds ownership: 44.65% → 43.26% (-1.4%)
16% less capital invested
Capital invested by funds: $372M → $313M (-$58.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$6.81M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$5.93M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$2.38M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$9.16M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$7.2M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.11M |
| 4 |
Blackstone Inc
New York
|
-$4.07M |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$2.86M |
ABVX Hedge Fund Activity: Q3 2024 in Review
40 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Abivax (ABVX) for Q3 2024, worth a combined $313M — down 16% from $372M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ABVX positions and 2 closed out — a net gain of 2 holders — while 17 added to existing stakes and 11 trimmed.
The largest buyer was Millennium Management, adding an estimated $6.81M. The largest seller was Janus Henderson Group, cutting an estimated $9.16M.
- 40 institutional investors held Abivax (ABVX) as of Q3 2024, up from 38 in Q2 2024.
- Funds reported $313M of Abivax stock for Q3 2024, down 16% quarter-over-quarter.
- 4 funds opened new Abivax positions in Q3 2024 and 2 closed out, a net change of +2 holders.
- The largest Abivax buyer in Q3 2024 was Millennium Management, an estimated $6.81M added.
- The largest Abivax seller in Q3 2024 was Janus Henderson Group, an estimated $9.16M sold.
Based on aggregated 13F filings for Q3 2024.